Language
Paratek Pharmaceuticals to Be Acquired in Deal Worth Up to $462 Million >PRTK

Blog

HomeHome / Blog / Paratek Pharmaceuticals to Be Acquired in Deal Worth Up to $462 Million >PRTK
search

Jun 26, 2023

Cuyuna Rock Club agate and mineral show set May 13

Jun 24, 2023

FREMONT ANNOUNCES: Signs Agreement on Vardenis Property in Armenia; Acquires Historic Data from Dundee Precious Metals; Applies for Exploration License over Urasar Mineral District in Northern Armenia

Aug 02, 2023

Neem leaf powder (Azadirachta indica) mitigates oxidative stress and pathological alterations triggered by lead toxicity in Nile tilapia (Oreochromis niloticus)

Oct 09, 2023

Ginkgo Bioworks and Centrient Pharmaceuticals Announce Expansion of Partnership Following Success of Initial Project to Bring Sustainable Innovation to the Generic API Space

Oct 18, 2023

Univar Solutions Expands Specialty Pharmaceutical and Nutraceutical Ingredient Portfolios with Grace SYLOID® FP Silica for Majority of Europe

Send your inquiry
SUBMIT

Jun 12, 2023

Paratek Pharmaceuticals to Be Acquired in Deal Worth Up to $462 Million >PRTK

By Colin Kellaher Paratek Pharmaceuticals on Tuesday said it agreed to be

By Colin Kellaher

Paratek Pharmaceuticals on Tuesday said it agreed to be acquired by a pair of healthcare investors in a deal valued at up to $462 million, including the assumption of debt.

Under the agreement, healthcare-investment firm Gurnet Point Capital and investment and holdings company Novo Holdings would pay an initial $2.15 a share in cash for the Boston biopharmaceutical company, a 9.7% premium to Monday's closing price of $1.96.

Paratek said its shareholders would also receive contingent value rights tied to commercial milestone that are potentially worth another 85 cents a share, bringing the total potential deal value to $3 a share, a 53% premium.

The transaction is slated to close in the third quarter.

Novo Holdings is owned by the Novo Nordisk Foundation, a Danish organization that controls healthcare giant Novo Nordisk.

Trading in shares of Paratek was halted premarket on Tuesday.

Write to Colin Kellaher at [email protected]

Even if the Federal Reserve skips a June rate hike to give 5% rates more time to sink in, stocks, bond and the economy still face challenges.

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing opportunities, strengthen advisor-client relationships and build investor experiences. Learn More.